The pharmaceutical industry constantly seeks high-purity, versatile intermediates to streamline the synthesis of complex active pharmaceutical ingredients (APIs). Among these critical building blocks, Dimethyluree, specifically the isomer Urea,N,N'-dimethyl (CAS No. 96-31-1), stands out for its unique chemical properties and broad utility. This compound serves as a cornerstone in the synthesis of several vital pharmaceuticals, demonstrating its indispensable role in advancing therapeutic solutions. With over 20 years of dedicated expertise in producing this essential chemical, our company ensures a reliable supply of high-grade Dimethyluree to partners worldwide, supporting innovation from laboratory research to full-scale production.

Chemical Profile and Specifications of Dimethylurea
To understand its pharmaceutical value, one must first examine the fundamental characteristics of Dimethyluree. This organic compound, with the linear formula (CH₃NH)₂CO, offers a stable and reactive urea derivative ideal for further chemical transformations. Its consistent quality is paramount for pharmaceutical synthesis, which is why we adhere to stringent production and quality control protocols.
The key specifications of our pharmaceutical-grade Urea,N,N'-dimethyl are detailed below:
|
Parameter |
Specification |
|
Non pwodwi |
N,N'-Dimethyl urea; 1,3-Dimethyluree; Dimethyluree |
|
Nimewo CAS |
96-31-1 |
|
Molecular Formula |
C₃H₈N₂O |
|
Molecular Weight |
88.11 g/mol |
|
Appearance |
Colorless to white crystalline powder |
|
Primary Use |
Pharmaceutical intermediate / API building block |
|
Key Advantage |
Formaldehyde-free, high purity suitable for synthesis |
The Synthesis Pathways of Pharmaceutical Dimethylurea
The significance of CAS No. 96-31-1 in pharmaceuticals is profoundly illustrated by its role as a direct precursor to key methylxanthine derivatives. Its structured molecular framework allows for efficient ring closure reactions, forming the purine backbone essential for several central nervous system stimulants and bronchodilators.
Primarily, Dimethyluree is a critical starting material in the classical synthesis of Caffeine and Theophylline. Theophylline, a mainstay in treating respiratory diseases like asthma and COPD, relies on efficient and scalable production pathways where Urea,N,N'-dimethyl is a fundamental component. Furthermore, its utility extends to the synthesis of more specialized compounds such as N,N'-acetyl dimethyl urea and key intermediates like 6-AMINO-1,3-DIMETHYL-5-NITROSOURACIL. This versatility makes it a valuable asset in medicinal chemistry for constructing heterocyclic compounds, which are prevalent in a vast array of modern drugs targeting various diseases.
Advantages of Sourcing High-Purity Dimethylurea
For pharmaceutical manufacturers, the consistency and purity of raw materials are non-negotiable. Sourcing Dimethyluree from a specialist supplier like our company offers distinct advantages. Our product is characterized by its high purity, which minimizes unwanted side reactions and simplifies purification steps in downstream API manufacturing, leading to higher yields and cost efficiency. Importantly, our production process ensures the final product is free from formaldehyde, a common concern with other resin-based chemicals, thereby enhancing safety for both handlers and the final drug product.
Our two decades of experience translate into a deep understanding of the stability and handling requirements of CAS No. 96-31-1. We provide comprehensive support, including detailed Technical Data Sheets (TDS) and Material Safety Data Sheets (MSDS), and can tailor specifications to meet unique client requirements. Our global logistics network ensures reliable delivery, with standard lead times within 10 days after payment confirmation, supporting just-in-time production schedules.
Dimethylurea Pharmaceutical Applications and Client FAQs
We collaborate closely with our clients to ensure our Dimethyluree meets their specific application needs. Here are answers to some frequently asked questions from our pharmaceutical industry partners.
What are the key benefits of your Dimethylurea for API synthesis?
Our Dimethyluree offers exceptional batch-to-batch consistency and high chemical purity (>99%), which is critical for predictable and scalable pharmaceutical reactions. Its role as a direct precursor to methylxanthines like theophylline is well-established, providing a reliable pathway for API manufacturers. Our formaldehyde-free process adds an extra layer of safety and quality.
Can you provide Dimethylurea that meets our custom specifications?
Absolutely. While we maintain standard high-grade Urea,N,N'-dimethyl, our technical team can review your specific specifications for particle size, purity thresholds, or packaging. We have the capability to customize our product to fit your unique synthesis process, ensuring optimal performance in your manufacturing line.
How do you ensure the quality of CAS No. 96-31-1?
Quality is assured through a multi-step process. We employ stringent in-process controls and state-of-the-art analytical methods (including HPLC and GC) for final verification. We are also open to third-party inspection and can provide references from existing global pharmaceutical clients who use our Dimethyluree successfully.
What is the MOQ for pharmaceutical-grade Dimethylurea?
We support both research and bulk manufacturing needs. The typical Minimum Order Quantity (MOQ) starts at 1kg for R&D purposes, facilitating early-stage drug development. For commercial production, we offer competitive pricing on multi-ton orders, ensuring a seamless scale-up from lab to plant.
How is Dimethylurea shipped globally?
We encourage testing and offer free samples of our Dimethyluree; clients only cover the delivery cost. For bulk orders, we ship globally from major Chinese ports. We accept flexible payment terms including T/T and L/C, and aim to dispatch all orders within 10 working days after payment clearance.
For your next pharmaceutical synthesis project requiring a reliable, high-purity intermediate, partner with Shijiazhuang Kunxiangda Technology Co., Ltd. Our expertise in producing Dimethylurea (CAS No. 96-31-1) is backed by over a decade of dedicated manufacturing experience, a modern production facility, and a proven commitment to quality that has earned the trust of clients worldwide. As a professional manufacturer with strong technical partnerships and a mature global supply network, we understand the critical role of consistent, high-grade intermediates like ours in synthesizing foundational APIs such as theophylline and caffeine. We are committed to being your most reliable partner, ensuring your supply chain is secure and your quality standards are met. Contact Shijiazhuang Kunxiangda Technology today to discuss your specifications, request a sample of our pharmaceutical-grade Dimethylurea, and experience the advantage of collaborating with a focused and customer-centric supplier. Let's build the future of medicine together.

